S2470 Silent Synergy: A 25-Year US Analysis of Sepsis-Related Mortality in Older Adults With Chronic Liver Disease

Introduction: Chronic liver disease (CLD) compromises immune surveillance, gut barrier integrity, and systemic inflammatory regulation, rendering patients highly susceptible to severe infections, particularly sepsis. Older adults with CLD face a disproportionately high risk due to age-related immunosenescence and frequent co-morbidities. Sepsis not only accelerates hepatic decompensation but also dramatically worsens outcomes, often leading to multi-organ failure and death. Despite the growing recognition of sepsis as a leading cause of hospitalization in CLD, national mortality trends in this vulnerable subgroup remain poorly characterized. This study analyzes long-term trends and disparities in CLD and sepsis-related deaths among U.S. adults aged 55+ from 1999 to 2023. Methods: We extracted mortality data from CDC WONDER (1999–2023) using International Classification of Diseases, Tenth Revision codes for CLD and sepsis. Age-adjusted mortality rates (AAMRs) per 100,000 were calculated using the 2000 U.S. standard population. Joinpoint regression estimated Annual Percent Change (APC) and Average APC (AAPC), with P < 0.05 considered significant. Results: There were 137,129 deaths from CLD and sepsis among adults ≥55, with 82% occurring in inpatient settings. The AAMR more than doubled, rising from 4.12 (1999) to 9.88 (2023) (AAPC: 4.0%, 95% CI: 3.6–4.4, P < 0.000001). Men had nearly twice the mortality of women (8.3 vs 4.9), though women had a steeper increase (AAPC: 4.6% vs 4.2%). Adults aged 55–74 had higher AAMRs than those 75+, but older adults showed faster increases (AAPC: 4.5% vs 3.6%). Non-Hispanic American Indians had the highest AAMR (17.1) and steepest rise (AAPC: 4.7%, P < 0.00001). Regionally, the West had the highest AAMR (8.33) and fastest increase (AAPC: 4.4%). Kentucky reported the highest state-level AAMR (13.9), while Maine had the lowest (3.2). Urban areas had slightly higher mortality (6.5 vs 5.8), but rural areas saw faster growth (AAPC: 5.9% vs 3.6%). Conclusion: Mortality from CLD and sepsis in older adults has surged over 2 decades, with marked disparities by sex, age, race, and geography. Sharp increases among women, the elderly, NH American Indians, and rural populations highlight the need for tailored interventions. Elevated and rising rates in regions like the West and states like Kentucky reveal urgent care gaps. These findings underscore the importance of early recognition, integrated care models, and targeted public health strategies to reduce preventable deaths.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001137340.07529.85
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S2470 Silent Synergy: A 25-Year US Analysis of Sepsis-Related Mortality in Older Adults With Chronic Liver Disease

Muhammad Amin, Saman Javaid, Husnain Ahmad, Matthew Antony Manoj et al.
The American Journal of Gastroenterology
Liver Disease and Transplantation
article

S2470 Silent Synergy: A 25-Year US Analysis of Sepsis-Related Mortality in Older Adults With Chronic Liver Disease

Muhammad Amin, Saman Javaid, Husnain Ahmad, Matthew Antony Manoj, Jaideep Sandhu, Mohammad Kaisarul Islam, Shivani Joshi, Muhammad Faizan Ali, Muhammad Khan, Sherif Eltawansy, Noor ul Ain Saleem, Corinne Caissie
article en

Abstract

Introduction: Chronic liver disease (CLD) compromises immune surveillance, gut barrier integrity, and systemic inflammatory regulation, rendering patients highly susceptible to severe infections, particularly sepsis. Older adults with CLD face a disproportionately high risk due to age-related immunosenescence and frequent co-morbidities. Sepsis not only accelerates hepatic decompensation but also dramatically worsens outcomes, often leading to multi-organ failure and death. Despite the growing recognition of sepsis as a leading cause of hospitalization in CLD, national mortality trends in this vulnerable subgroup remain poorly characterized. This study analyzes long-term trends and disparities in CLD and sepsis-related deaths among U.S. adults aged 55+ from 1999 to 2023. Methods: We extracted mortality data from CDC WONDER (1999–2023) using International Classification of Diseases, Tenth Revision codes for CLD and sepsis. Age-adjusted mortality rates (AAMRs) per 100,000 were calculated using the 2000 U.S. standard population. Joinpoint regression estimated Annual Percent Change (APC) and Average APC (AAPC), with P < 0.05 considered significant. Results: There were 137,129 deaths from CLD and sepsis among adults ≥55, with 82% occurring in inpatient settings. The AAMR more than doubled, rising from 4.12 (1999) to 9.88 (2023) (AAPC: 4.0%, 95% CI: 3.6–4.4, P < 0.000001). Men had nearly twice the mortality of women (8.3 vs 4.9), though women had a steeper increase (AAPC: 4.6% vs 4.2%). Adults aged 55–74 had higher AAMRs than those 75+, but older adults showed faster increases (AAPC: 4.5% vs 3.6%). Non-Hispanic American Indians had the highest AAMR (17.1) and steepest rise (AAPC: 4.7%, P < 0.00001). Regionally, the West had the highest AAMR (8.33) and fastest increase (AAPC: 4.4%). Kentucky reported the highest state-level AAMR (13.9), while Maine had the lowest (3.2). Urban areas had slightly higher mortality (6.5 vs 5.8), but rural areas saw faster growth (AAPC: 5.9% vs 3.6%). Conclusion: Mortality from CLD and sepsis in older adults has surged over 2 decades, with marked disparities by sex, age, race, and geography. Sharp increases among women, the elderly, NH American Indians, and rural populations highlight the need for tailored interventions. Elevated and rising rates in regions like the West and states like Kentucky reveal urgent care gaps. These findings underscore the importance of early recognition, integrated care models, and targeted public health strategies to reduce preventable deaths.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 48%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.